|
|
|
|
|
|
Sponsors and Collaborators: |
3M University of Nebraska |
Information provided by: | 3M |
ClinicalTrials.gov Identifier: | NCT00516906 |
Evaluate the clinical performance of a new IV Dressing in Comparison to a standard IV Dressing
Condition | Intervention | Phase |
Catheterization |
Drug: Chlorhexidine gluconate Drug: Non-antimicrobial Transparent Adhesive Dressing |
Phase II Phase III |
ChemIDplus related topics: | Chlorhexidine Chlorhexidine digluconate D-Gluconic acid, monosodium salt Gluconic acid Manganese gluconate |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind (Subject), Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Clinical Performance of a Chlorhexidine Antimicrobial Dressing |
Enrollment: | 63 |
Study Start Date: | October 2007 |
Study Completion Date: | January 2008 |
Primary Completion Date: | December 2007 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
A: Placebo Comparator
Standard of Care Transparent Adhesive Dressing
|
Drug: Non-antimicrobial Transparent Adhesive Dressing
Standard of Care Non-antimicrobial Transparent Adhesive Dressing applied as needed for up to 7 days of wear
|
B: Experimental
Chlorhexidine gluconate antimicrobial transparent adhesive dressing
|
Drug: Chlorhexidine gluconate
2% Chlorheidine Transparetn Dressing applied as needed upto 7 days of wear
|
Prospective, controlled, randomized, clinical trial comparing the 3M™ TegadermTM CHG (Chlorhexidine Gluconate) IV Securement Dressing (3M Healthcare, St Paul, MN) to a standard transparent dressing.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | 3M Health Care ( JM Heilman; Sr. Clinical Research Specialist ) |
Study ID Numbers: | 05-010691 |
First Received: | August 14, 2007 |
Last Updated: | May 29, 2008 |
ClinicalTrials.gov Identifier: | NCT00516906 |
Health Authority: | United States: Institutional Review Board |
|
|
|